Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Similarly, the metabolic syndrome, was a significant predictor of diabetes with twice as many having the syndrome among the diabetes group (84.6 versus 44.9%, p-value = 0.008).Comparison of probable diabetes vs low risk (LR)/high risk (HR) of diabetes with all the variables at baseline in 2014VariablesLow/high risk of diabetes n = 138Probable diabetes N = 13p-valueDemographic AgeMean (± SD)44.3 ± 13.350.7 ± 10.80.12 GenderFemale86 (62.3)7 (53.8)0.56 Marital statusMarried108 (78.3)10 (76.9)0.10Single19 (13.8)0 (0.0)Other11 (8.0)3 (23.1) Income < 1000 $104 (80.6)9 (69.2)0.30 ≥ 1000 $25 (19.4)4 (30.8) EducationNo schooling/primary school51 (37.2)2 (15.4)0.37Intermediate school41 (29.9)6 (46.2)Secondary school/technical diploma33 (24.1)3 (23.1)University degree12 (8.8)2 (15.4)Lifestyle habits SmokingNever31 (22.5)3 (23.1)0.01Current93 (67.4)5 (38.5)Former14 (10.1)5 (38.5) Current alcohol drinkerYes23 (16.7)1 (7.7)0.69 Coffee drinkerYes113 (81.9)10 (76.9)0.71 Sleep apnea indexLow risk87 (71.9)3 (33.3)0.02High risk34 (28.1)6 (66.7) Any physical activity120 (87.0)10 (76.9)0.32 Physical activity statusLow61 (44.2)7 (53.8)0.69Moderate49 (35.5)5 (38.5)High28 (20.3)1 (7.7) Specific nutrition items consumption per 24 h Coffee consumption/ mgramsMedian (IQR)225.9 (283.5)161.2 (243.3)0.55 Coffee cups/ numberMedian (IQR)2.7 (3.6)3.0 (3.4)0.92 Dairy consumption / gramsMedian (IQR)119.6 (181.0)209.8 (251.5)0.53 Fruits/gramsMedian (IQR)197.4 (190.3)203.6 (204.2)0.75 Vegetables/ gramsMedian (IQR)110.8 (177.1)164.1 (209.3)0.78 Fruits/KCalMedian (IQR)125.1 (131.7)139.9 (124.0)0.86 Vegetables/ KCalMedian (IQR)77.8 (63.3)59.2 (64.6)0.84 Glycemic loadMedian (IQR)208.9 (123.2)186.2 (272.5)0.87 Glycemic indexMean (± SD)61.5 ± 7.264.1 ± 9.00.22 Sweetened beverages/ gramsMedian (IQR)127.4 (227.8)188.6 (291.6)0.92Fruit juices fresh /gramsMedian (IQR)37.6 (78.4)11.6 (33.4) < 0.0001Medical history Hypertension diagnosisYes12 (8.7)2 (15.4)0.35 Hypertension treatmentYes11 (8.0)1 (7.7)1.00 Dyslipidemia diagnosisYes23 (16.7)4 (30.8)0.25 Dyslipidemia treatmentYes18 (13.0)3 (23.1)0.40Obesity indicators and vital signs Systolic blood pressure mmHgMean (± SD)118.8 ± 17.2121.3 ± 18.30.66 Diastolic blood pressure mmHgMean (± SD)74.4 ± 10.377.3 ± 9.70.40 Heart rate (bpm)Mean (± SD)77.7 ± 10.076.3 ± 11.60.46 BMIMean (± SD)28.6 ± 5.133.5 ± 4.20.001 Waist circumference (cm)Mean (± SD)93.2 ± 12.3108.2 ± 10.3 < 0.0001 Body fat (kg)Mean (± SD)27.5 ± 10.437.2 ± 7.60.001 Muscle Mass (kg)Mean (± SD)26.7 ± 6.429.7 ± 7.90.20 Metabolic syndromeYes62 (44.9)11 (84.6)0.008Laboratory measures HBA1C (%)Mean (± SD)5.5 ± 0.45.8 ± 0.20.001 Fasting plasma glucose (mg/dL)Mean (± SD)98.3 ± 9.0104.5 ± 9.30.03 Fingerstick glucose (mg/dL)Mean (± SD)100.2 ± 8.1105.5 ± 8.10.04 HOMA-IRMedian (IQR)6.3 (3.5)8.9 (4.9)0.002 Creatinine (mg/dL)Mean (± SD)0.8 ± 0.20.8 ± 0.10.52 Insulin (IU/mL)Median (IQR)25.6 (12.6)36.5 (14.7)0.004 C-reactive protein (mg/dL)Median (IQR)9.0 (7.0)13.0 (16.0)0.03 HDL-C (mg/dL)Median (IQR)49.0 (19)42.0 (12.0)0.01 LDL-C (mg/dL)Median (IQR)109.5 (42.0)104.0 (35.0)0.63 Triglyceride (mg/dL)Median (IQR)106.5 (96.0)183.0 (81.0)0.03 Vitamin D (ng/dL)Mean (± SD)16.0 ± 8.616.5 ± 8.60.52 Urine microalbumin/creatinine ratio (ug/gm)Median (IQR)58.6 (133.8)84.4 (55.1)0.85Significance was considered at a p value < 0.05*ND no Diabetes or euglycemic, RD at risk for diabetes or prediabetes
Source: Risk factors for the development of diabetes. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
This study is based on the Greater Beirut Area Cardiovascular Cohort study, which was originally initiated in 2014.
Source: Methods.
Participants were instructed to come after a 10-h fast, and to bring their current medications with them.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Incidence of diabetes and its predictors in the Greater Beirut Area: a five-year longitudinal study
Cohort study · Diabetology & Metabolic Syndrome · 2022
Original publication title
Incidence of diabetes and its predictors in the Greater Beirut Area: a five-year longitudinal study
© The Author(s) 2022
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Type 2 Diabetes (T2D) remains a world epidemic. Obtaining accurate estimates of its incidence and their predictors will aid in targeting preventive measures, allocating resources, and strategizing its management. The Middle East North Africa region has high T2D prevalence and rates of rise. Few incidence studies exist for the region, and none from Lebanon. The current study objective was to determine diabetes incidence and diabetes predictors in a community-based Lebanese sample. A secondary objective was to describe the metabolic control over time in adults with preexisting diabetes.
Source: BackgroundAbstract: What methods does the paper describe?
This is a five-year (2014 to 2019) follow-up study on a random sample of 501 residents of the Greater Beirut area. Out of 478 people eligible to participate in the follow-up study, 198 returned (response rate 39.5%). Assessment included medical history, anthropometric measures, food frequency, sleep, and lifestyle questionnaires. Laboratory data included glycemic indices (fasting glucose and HbA1C) and other biological markers. The diagnosis of probable diabetes (PD) was based on one abnormal test for either fasting glucose ≥ 126 mg/dL or HbA1C ≥ 6.5% or having history of diabetes.
Source: MethodsAbstract: Results
The incidence of diabetes was 17.2 (95% CI 9.6 to 28.7) per 1000 person-years. Cardiometabolic risk factors independently associated with diabetes were: older age, higher BMI, family history of diabetes, metabolic syndrome, higher CRP and triglyceride level; whereas an independent predictor of diabetes was previous BMI.
In addition, the 42 participants with preexisting diabetes had worsening of their metabolic profile over a five-year period.
Source: Results Source: ResultsAbstract: Conclusions
The incidence of diabetes was high as compared to some reported world rates, and in line with the high prevalence in the MENA region. The risk was highest in those with positive family history and the presence of the metabolic syndrome or its components. Preventive measures should particularly target participants with that specific risk profile. This becomes particularly important when observing that metabolic control gets worse over time in individuals with diabetes.
Source: ConclusionsAuthors’ abstract
Background
Type 2 Diabetes (T2D) remains a world epidemic. Obtaining accurate estimates of its incidence and their predictors will aid in targeting preventive measures, allocating resources, and strategizing its management. The Middle East North Africa region has high T2D prevalence and rates of rise. Few incidence studies exist for the region, and none from Lebanon. The current study objective was to determine diabetes incidence and diabetes predictors in a community-based Lebanese sample. A secondary objective was to describe the metabolic control over time in adults with preexisting diabetes.
Methods
This is a five-year (2014 to 2019) follow-up study on a random sample of 501 residents of the Greater Beirut area. Out of 478 people eligible to participate in the follow-up study, 198 returned (response rate 39.5%). Assessment included medical history, anthropometric measures, food frequency, sleep, and lifestyle questionnaires. Laboratory data included glycemic indices (fasting glucose and HbA1C) and other biological markers. The diagnosis of probable diabetes (PD) was based on one abnormal test for either fasting glucose ≥ 126 mg/dL or HbA1C ≥ 6.5% or having history of diabetes.
Results
The incidence of diabetes was 17.2 (95% CI 9.6 to 28.7) per 1000 person-years. Cardiometabolic risk factors independently associated with diabetes were: older age, higher BMI, family history of diabetes, metabolic syndrome, higher CRP and triglyceride level; whereas an independent predictor of diabetes was previous BMI.
In addition, the 42 participants with preexisting diabetes had worsening of their metabolic profile over a five-year period.
Conclusions
The incidence of diabetes was high as compared to some reported world rates, and in line with the high prevalence in the MENA region. The risk was highest in those with positive family history and the presence of the metabolic syndrome or its components. Preventive measures should particularly target participants with that specific risk profile. This becomes particularly important when observing that metabolic control gets worse over time in individuals with diabetes.
Supplementary Information
The online version contains supplementary material available at 10.1186/s13098-022-00833-w.
Publication and source details
Original title: Incidence of diabetes and its predictors in the Greater Beirut Area: a five-year longitudinal study
Mona P. Nasrallah; Martine Elbejjani; Lara Nasreddine; Hassan Chami; Hussein Ismaeel; Mohamad Fleifel; Fatima Al Zahraa Chokor; Hani Tamim
Diabetology & Metabolic Syndrome · 2022
© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T09:18:30.599247+00:00
DOI: 10.1186/s13098-022-00833-w · PMC9066987